BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37013535)

  • 1. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
    Ninsiima M; Nyabigambo A; Kagaayi J
    BMC Health Serv Res; 2023 Apr; 23(1):333. PubMed ID: 37013535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda.
    Kumakech E; Andersson S; Wabinga H; Berggren V
    BMC Womens Health; 2015; 15():23. PubMed ID: 25783655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
    BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
    Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
    Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations and barriers to cervical cancer screening among HIV infected women in HIV care: a qualitative study.
    Bukirwa A; Mutyoba JN; Mukasa BN; Karamagi Y; Odiit M; Kawuma E; Wanyenze RK
    BMC Womens Health; 2015 Oct; 15():82. PubMed ID: 26458898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda.
    Kumakech E; Andersson S; Wabinga H; Berggren V
    BMC Public Health; 2014 Aug; 14():810. PubMed ID: 25099996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of Integrated Community-Based HIV and Cervical Cancer Screening in Mayuge District, Uganda.
    Mezei A; Trawin J; Payne B; Rawat A; Naguti P; Orem J; Murray MCM; Nakisige C; Ogilvie G
    JCO Glob Oncol; 2024 Jan; 10():e2200324. PubMed ID: 38237095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study.
    Sarah Maria N; Olwit C; Kaggwa MM; Nabirye RC; Ngabirano TD
    BMC Womens Health; 2022 May; 22(1):148. PubMed ID: 35538482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Rawat A; Sanders C; Mithani N; Amuge C; Pedersen H; Namugosa R; Payne B; Mitchell-Foster S; Orem J; Ogilvie G; Nakisige C
    Int J Gynaecol Obstet; 2021 Jan; 152(1):103-111. PubMed ID: 33128778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics.
    Plotkin M; Besana GV; Yuma S; Kim YM; Kulindwa Y; Kabole F; Lu E; Giattas MR
    BMC Womens Health; 2014 Sep; 14():120. PubMed ID: 25271025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of cervical cancer screening in HIV-positive women in Zimbabwe.
    Mpata PC; Nkosi ZZ
    Curationis; 2021 Nov; 44(1):e1-e7. PubMed ID: 34797107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.
    Fletcher FE; Buchberg M; Schover LR; Basen-Engquist K; Kempf MC; Arduino RC; Vidrine DJ
    AIDS Care; 2014; 26(10):1229-35. PubMed ID: 24635664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
    BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating cervical cancer with HIV healthcare services: A systematic review.
    Sigfrid L; Murphy G; Haldane V; Chuah FLH; Ong SE; Cervero-Liceras F; Watt N; Alvaro A; Otero-Garcia L; Balabanova D; Hogarth S; Maimaris W; Buse K; Mckee M; Piot P; Perel P; Legido-Quigley H
    PLoS One; 2017; 12(7):e0181156. PubMed ID: 28732037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss to follow-up and associated maternal factors among HIV-exposed infants at the Mbarara Regional Referral Hospital, Uganda: a retrospective study.
    Ankunda R; Cumber SN; Atuhaire C; Kabanda T; Nkfusai CN; Wirsiy FS; Turyakira E
    BMC Infect Dis; 2020 Mar; 20(1):235. PubMed ID: 32192458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
    Gebrekirstos LG; Gebremedhin MH; Tafesse TT; Tura TS; Geleso MG; Wube TB
    Cancer Control; 2022; 29():10732748221126944. PubMed ID: 36112936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
    Yahya A; Mustapha A; Kolawole AOD; Oguntayo AO; Lawal BK
    West Afr J Med; 2022 Mar; 39(3):291-298. PubMed ID: 35380751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
    New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.